Capstone Investment Advisors
BLFS icon

Capstone Investment Advisors’s BioLife Solutions BLFS Stock Holding History

Capstone Investment Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,577
Closed -$397K – 1623
2025
Q3 		$397K Buy
+15,577
New +$370K ﹤0.01% 1522

Other funds holding BLFS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capstone Investment Advisors's BLFS Position: Q4 2025 in Review

Capstone Investment Advisors sold out of BioLife Solutions (BLFS) in Q4 2025, closing a stake of 15,577 shares — an estimated $397K sold.

Capstone Investment Advisors first reported a position in BLFS in Q3 2025 and held it in 1 quarter. The position peaked at $397K in Q3 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • Capstone Investment Advisors reported no remaining BioLife Solutions position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 15,577 BioLife Solutions shares in Q4 2025, an estimated $397K.
  • Capstone Investment Advisors first reported a position in BioLife Solutions in Q3 2025 and held it in 1 quarter.
  • Capstone Investment Advisors's BioLife Solutions position peaked at $397K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.